about
Retardation of retinal vascular development in apelin-deficient miceTranscriptional regulation of VEGFA by the endoplasmic reticulum stress transducer OASIS in ARPE-19 cellsThree-dimensional optical coherence tomographic findings of idiopathic multiple serous retinal pigment epithelial detachment.Evaluation of choroidal perfusion of the new central macular area by dilution analysis of indocyanine green angiography after macular translocation.A microperimeter that provides fixation pattern and retinal sensitivity measurement.Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.Polypoidal choroidal vasculopathy and treatments.Fundus autofluorescence after full macular translocation surgery for myopic choroidal neovascularization.Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment.Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy.Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.Axial length estimation error caused by hidden double-peak on partial coherence interferometry in an eye with epiretinal membrane: a case reportA Multicenter Randomized Controlled Study of Antioxidant Supplementation with Lutein for Chronic Central Serous Chorioretinopathy.En Face Optical Coherence Tomography Imaging of the Choroid in a Case with Central Serous Chorioretinopathy during the Course of Vogt-Koyanagi-Harada Disease: A Case Report.Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application.Induction of amyloid beta accumulation by ER calcium disruption and resultant upregulation of angiogenic factors in ARPE19 cells.Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress.A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice.[Benefit of ocular draping on bacterial contamination after intravitreal injection using a plate-type eyelid speculum].Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion.Long-term follow-up after vitrectomy to treat idiopathic full-thickness macular holes: visual acuity and macular complicationsBevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients.Angiographic changes after bevacizumab.Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization.Macular translocation surgery and retinal circulation times.New micro vertical scissors for the surgical ablation of retinal angiomatous proliferation.One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.Lacquer crack formation and choroidal neovascularization in pathologic myopia.Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.Recurrent retinal angiomatous proliferation after surgical ablation.Abnormal fundus autofluorescence patterns in myopic choroidal neovascularisation.Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.Age at onset curves of retinitis pigmentosa.Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator.Complications in patients after intravitreal injection of bevacizumab.
P50
Q28286058-F1DDBC82-2B2B-43A3-9542-A324FB8ED7A1Q28485361-B16034CF-EF5B-42DB-B061-64FC275BF0CEQ31140493-22A465F5-8910-4139-99EF-9FD117BC59A5Q33201986-02BDD26B-36A0-4D49-B68F-DEC3350CF075Q33239396-DF5E2878-1C87-4752-ACB7-9C93F5F34F9FQ33277543-0F09CB6E-8329-4419-BBF4-5A140D967457Q33288365-76EF835A-6E03-46B4-AF88-658809030DB4Q33327968-CCF86A9A-7E03-45E2-BE59-1E2826C476A2Q33331882-A85FF1FD-EBF1-4FBD-93C5-E525F134FF2DQ34003439-BE2BD7FF-4B37-478B-8B44-D49B7CBFDA60Q34099859-44C8C818-76B7-4D18-978E-BD325B4B88ABQ34818910-C020CA57-9071-436B-93C3-6880854B75FBQ37644576-EBF25A4A-DC59-4952-BBD3-DD26B022BFABQ38760315-D26424EC-D276-4B22-BEE2-09DB8A84508EQ38772562-1BB80390-25B1-4236-9BFC-705DF838151AQ39686947-F87210AB-3E06-4517-A114-2B26DF909C91Q39976606-0EF85BC0-270C-46BD-BD8F-44BED26DEBFCQ40454968-BDC5EAB4-8AB1-4188-8AE9-E61A4BD021D9Q41504310-FF14406E-0B39-48C7-8D58-6641951E426EQ41565626-58BDE0F0-410B-41AD-90C3-8DCD6F03DAADQ41738887-FF41CF2D-9CA2-4105-9331-BFCEB96E534CQ41948477-AD27D71B-EE5A-4148-B7D4-35F52E564B9DQ42281834-491C4A79-8399-4243-9437-D1E8721740C9Q43094462-AA97AF9F-4CA6-40BE-BF51-B36245E7CFD2Q43250203-CCA4A049-9D7A-408B-B1C8-11AE486FF19AQ43257422-E33AD64A-5787-478D-8C46-137430BFDD15Q44839102-0AEBFC5A-203D-476E-99C8-9C5F17E84D66Q45284594-B5BED1C8-7320-45B9-82BD-63EF2E256D46Q46077796-2E65D2D0-7723-48D0-A29D-0F24CB9ADF3DQ46380385-4B227304-5BA5-46E2-A358-41F991ECF004Q46386792-DC339A08-915C-4E6F-8DD3-D610154880E9Q46462730-7BBABED4-065B-4C85-8E8E-D2EB9A48CB1FQ46490443-D3C86A96-510A-48AB-A4AD-BD4E42DFDAA8Q46520531-D2FACC5A-8288-4D49-837D-7B3CA89DE660Q46545621-BFA8A067-0877-4AE2-ADD5-28C15574A347Q46623669-DDD3D569-3344-4517-8400-607784684C21Q46659824-2074CA2A-BC61-429B-85CE-823E9F28A58CQ46708810-E6C695B0-EBD9-40FB-85AF-DDD1B0F36624Q46718487-2F8DC22E-BA14-434F-9F4E-838DD3C03B53Q46889796-41BA2795-7D9B-4485-8D48-D20DBA74C306
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fumi Gomi
@ast
Fumi Gomi
@en
Fumi Gomi
@es
Fumi Gomi
@nl
Fumi Gomi
@sl
type
label
Fumi Gomi
@ast
Fumi Gomi
@en
Fumi Gomi
@es
Fumi Gomi
@nl
Fumi Gomi
@sl
prefLabel
Fumi Gomi
@ast
Fumi Gomi
@en
Fumi Gomi
@es
Fumi Gomi
@nl
Fumi Gomi
@sl
P106
P21
P31
P496
0000-0003-0807-8817
P569
2000-01-01T00:00:00Z